An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for ALNYLAM PHARMACEUTICALS Inc
| Ticker | ALNY |
| FIGI | BBG000BFGNJ5 |
| CUSIP | 02043Q107 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 500 / 7.1% |
| Percentage held by institutional investors | 100.0% |
About
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia